ANN Arbor Dialysis Of Davita is a medicare approved dialysis facility center in Ann Arbor, Michigan and it has 16 dialysis stations. It is located in Washtenaw county at 3147 Oak Valley Dr, Ann Arbor, MI, 48108. You can reach out to the office of ANN Arbor Dialysis Of Davita at (734) 213-5269. This dialysis clinic is managed and/or owned by Davita. ANN Arbor Dialysis Of Davita has the following ownership type - Profit. It was first certified by medicare in January, 2013. The medicare id for this facility is 232687 and it accepts patients under medicare ESRD program.
| Name | ANN Arbor Dialysis Of Davita |
|---|---|
| Location | 3147 Oak Valley Dr, Ann Arbor, Michigan |
| No. of Dialysis Stations | 16 |
| Medicare ID | 232687 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 3147 Oak Valley Dr, Ann Arbor, Michigan, 48108 | |
| (734) 213-5269 | |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
| NPI Number | 1497014963 |
| Organization Name | Ann Arbor Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 3147 Oak Valley Dr Ann Arbor, Michigan, 48103 |
| Phone Number | (734) 213-5269 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
| Dialysis patients with Hemoglobin data | 27 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 11 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 58 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 410 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at ANN Arbor Dialysis Of Davita with elevated calcium levels.
| Patients with hypercalcemia | 60 |
| Hypercalcemia patient months | 430 |
| Patients with Serumphosphor | 67 |
| Patients with Serumphosphor less than 3.5 mg/dL | 5 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 38 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 23 |
| Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 56 |
| Patient months included in arterial venous fistula and catheter summaries | 287 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 59 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 13 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 42 |
| Hospitalization Rate in facility | 232.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 412.9 |
| Hospitalization Rate: Lower Confidence Limit | 136.9 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at ANN Arbor Dialysis Of Davita were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 28.1 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 42.8 |
| Readmission Rate: Lower Confidence Limit | 16.4 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at ANN Arbor Dialysis Of Davita get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 4.41 (Worse than Expected) |
| SIR: Upper Confidence Limit | 7.49 |
| SIR: Lower Confidence Limit | 2.39 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether ANN Arbor Dialysis Of Davita's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 31 |
| Transfusion Rate in facility | 47.7 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 166.3 |
| Transfusion Rate: Lower Confidence Limit | 15.9 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
The rate of mortality show you whether patients who were being treated regularly at ANN Arbor Dialysis Of Davita lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 214 |
| Mortality Rate in facility | 15.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 22.9 |
| Mortality Rate: Lower Confidence Limit | 10.2 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago
Univ Of Mi Dialysis - Pediatric Location: 1540 E Hospital Dr Rm 10-712, Ann Arbor, Michigan, 48109 Phone: (734) 232-5461 |
Michigan Dialysis Services Of Ann Arbor Location: 2850 S Industrial Hwy Ste 100, Ann Arbor, Michigan, 48104 Phone: (734) 677-1490 |
FMC Dialysis - West Ann Arbor Location: 2355 W Stadium Blvd, Ann Arbor, Michigan, 48103 Phone: (734) 623-2259 |
ANN Arbor Dialysis Of Davita Location: 3147 Oak Valley Dr, Ann Arbor, Michigan, 48108 Phone: (734) 213-5269 |
FMC - East Ann Arbor Home Dialysis Location: 4949 Washtenaw Ave, Ann Arbor, Michigan, 48108 Phone: (734) 434-0059 |
News Archive
Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced positive results from a phase 2 study evaluating the effects of a once-monthly injectable suspension formulation of exenatide on glycemic control in patients with type 2 diabetes.
Merge Healthcare Incorporated and AMICAS, Inc. today announced that the tender offer by Project Ready Corp., a wholly-owned subsidiary of Merge Healthcare, for all of the outstanding shares of AMICAS common stock has been extended to 5:00 p.m., New York City, New York time, on Friday, April 23, 2010, unless further extended.
The U.S. Food and Drug Administration today released a listing of consumer health information updates about cooperative programs and food safety. All updates can be accessed from the agency's Web page for consumers at http://www.fda.gov/ForConsumers/default.htm You can sign-up for e-mail notices of new consumer updates on an immediate, weekly, or monthly basis at https://service.govdelivery.com/service/subscribe.html?code=USFDA_9.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, and Hitachi-Aloka Medical, a global leader in ultrasound imaging, recently announced renewed collaborative efforts between the two global companies to enable further innovation in the development of Endoscopic Ultrasound Systems.
› Verified 3 days ago